梅州非特异性阴道炎原因梅州做假体鼻子多少钱,梅州有妇科的医院,梅州患了急性淋菌性尿道炎怎么治疗,梅州怀孕后什么时候能做打胎,梅州市妇科医院打胎,梅州怀孕几天做人流,梅州割双眼皮大概多少钱

BEIJING, July 15 (Xinhua) -- The Chinese Academy of Agricultural Sciences (CAAS) announced Friday that a group of international scientists has finished sequencing the genetic code of the potato.The Potato Genome Sequencing Consortium (PGSC), which is led by Chinese scientists and made up of 97 researchers from 14 countries, has sequenced the complete potato genome and published a report of its findings in the latest issue of the scientific journal Nature, said the CAAS.The research took six years and revealed that the potato contains about 39,000 genes, said the CAAS.Qu Dongyu, a potato farming specialist with the Crop Science Society of China and a promoter of the PGSC, said the study helped discover genes that define the growth and insect resistance of potatoes.The sequenced genome will enable scientists to create new varieties of potato that are high in yield and quality and more resistant to insects and diseases, he said.Huang Sanwen, a researcher with the CAAS and one of the three corresponding authors of the report, said the sequencing will also allow potato breeders to accelerate the breeding process of new seeds from 10 to 12 years to about 5 years.China is the world's top potato grower, with its farmers planting potatoes on nearly 90 million mu (6 million hectares) of land each year. The average yield per mu stands at 1,000 kg, only one-third of that harvested by countries with advanced technologies, Qu said.

CHICAGO, Aug. 25 (Xinhua) -- Gold futures on the COMEX Division of the New York Mercantile Exchange on Thursday bounced off the biggest drop since March 2008, as the weakness in stock market enhanced appeal of gold as a safe-have investment.The most active gold contract for Dec. delivery gained 5.9 U.S. dollars, or 0.3 percent, to 1,763.2 dollars per ounce. The metal suffered on Wednesday the biggest one-day drop since March 19, 2008.Market analysts said that gold extended losses in earlier trading, hit by a margin-requirement increase, but the drop in global stock market gave a push to the metal. Both Dow Jones industrial average and S&P 500 declined on Thursday after a 3-day rise as a government report showed U.S. jobless claims rose last week.Besides, market hearsay went that Germany might be next to get a sovereign-debt downgrade, adding to the positive tone on gold market. German equity market also suffered sharp drop in the day.Many market watchers remained long-term bullish attitude toward gold although they said the precious metal could correct further in the short term. A trader noted that the fundamental factors driving uncertainty and fears are all still there.Expectations are growing that the Federal Reserve Chairman Ben Bernanke would not provide any form of stimulus in a speech scheduled for Friday at a yearly gathering of central bankers in Jackson Hole.Silver for Sept. delivery also rose 1.583 dollars, or four percent, to 40.745 dollars per ounce. Platinum for Oct. delivery lost 3.9 dollars, or 0.2 percent, to 1822.4 dollars per ounce.

SINGAPORE, Sept. 7 (Xinhua) -- Singapore scientists have found possible new ways to treat a type of aggressive breast cancer that is unresponsive to current forms of treatment, local broadcaster Channel NewsAsia reported on Wednesday.The team of scientists at the Genome Institute of Singapore ( GIS) and National University of Singapore (NUS), led by GIS senior group leader Qiang Yu, found that the enzyme EZH2 acts by inhibiting genes that stop the growth of tumors in the body.The insights could open the door to developing more effective treatment for fast spreading breast cancers, especially the estrogen receptor-negative breast cancer that is common all over the world.It was also found that through EZH2, cancer is promoted in the body by activating specific genes that impact breast cancer progression and cancer stem cell self-renewal.Yu said the new understanding on how EZH2 works as a cancer- causing gene in breast cancer has important therapeutic implication."The results suggest that small molecule drugs that block enzyme activity of EZH2 may not work for cancers caused by EZH2's activation genes," Yu said.Currently pharmaceutical companies have been developing drugs only to the block EZH2 enzyme activity so that tumor suppressers can perform their protective role in blocking cancer growth.Researchers said the next step would be to develop biomarkers to identify tumors with EZH2.This step would enable better treatment methods, with one of options being the development of therapies that shut down EZH2 completely and not just inhibit its enzymatic function.The findings have been published on the journal Molecular Cell.

WASHINGTON, July 5 (Xinhua) -- Intake of high levels of folate, a water-soluble B vitamin that occurs naturally in food, may reduce colorectal cancer risk, according to a new study published Tuesday in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute. "We found that all forms and sources of folate were associated with lower risk of colorectal cancer," said lead author Victoria Stevens, of the American Cancer Society. "The strongest association was with total folate, which suggests that total folate intake is the best measure to define exposure to this nutrient because it encompasses all forms and sources."Total folate includes naturally occurring food folate and folic acid from fortified foods and dietary supplements.The research team investigated the association between folate intake and colorectal cancer among 99,523 participants in the Cancer Prevention Study II Nutrition Cohort; a total of 1,023 participants were diagnosed with colorectal cancer between 1999 and 2007, a period entirely after folate fortification began. Neither higher nor lower risk was observed during the first two years of follow-up (1999 to 2001), while associations were statistically significantly inverse for the subsequent years (2002 to 2007). The findings of this study add to the epidemiologic evidence that high folate intake reduces colorectal cancer incidence.Folates are essential nutrients needed to make components used for functions required for normal cell growth, including DNA synthesis and repair. Because these processes are critical for cell growth and differentiation, the relationship between folate intake and cancer development has been investigated in several cancers, and most extensively in colorectal cancer.

SAN FRANCISCO, Sept. 13 (Xinhua) -- Intel and Google on Tuesday announced a partnership to enable the world's largest chip maker's architecture on the search giant's products, saying that an Intel chip-based Android smartphone will hit the market in the first half of 2012.In a joint press release, the two companies said the future versions of Android mobile operating system will support Intel's low power Atom processors, in addition to other architectures.At the Intel Developer Forum in San Francisco on Tuesday, Intel Chief Executive Officer Paul Otellini said the Intel smartphone chip is code-named Medfield and based on the company's own PC- based computer architecture.Otellini said multiple vendors around the world will launch the Medfield-based Android smartphones in the first half of 2012.Andy Rubin, senior vice president of mobile at Google, came on stage at the close of Otellini's keynote to hail the joint initiatives between the two companies.Intel has been struggling to get a bite of the booming market of smartphones and tablets. Most of the current mobile devices use chips based on architecture from ARM Holdings, which are considered more power efficient than Intel's products. Nokia had planned to ship smartphones with Intel chips this year, but it shifted to ARM-based phones with Windows Phone 7 system.Otellini said Intel will eventually have an advantage in supplying smartphone chips as the business is not established in terms of the final winner and performance of the products keeps growing.